
Italy · Medical devices startup
KLISBio is a clinical-stage medtech company based in Milan, Italy, focused on developing implantable regenerative solutions for soft tissue repair using natural silk fibroin.
Funding reportedLast round: Grant
Follow KLISBio and see its new rounds in your feed.Start following
KLISBio is a clinical-stage medtech company based in Milan, Italy, focused on developing implantable regenerative solutions for soft tissue repair using natural silk fibroin.
Founded in 2014, the company aims to enhance the body's healing processes through its innovative biocompatible materials. The company's flagship product, SILKBridge®, is a bioengineered nerve guide designed for peripheral nerve repair. It features a unique structure that mimics the extracellular matrix, providing mechanical strength and promoting cell growth. KLISBio is preparing for the commercial launch of SILKBridge® in the US, pending FDA clearance. Additionally, the company is developing vascular grafts, bone graft substitutes, and solutions for rotator cuff repair, all aimed at addressing various medical needs in orthopedics, vascular surgery, and nerve repair. KLISBio operates on a B2B model, supplying healthcare professionals and surgical specialists with advanced medical devices for tissue-related treatments. The company has successfully raised funding through grants and investments to support its mission in regenerative medicine.
Funding, as reported
From KLISBio's own website: 4 founders, 3 on the team.
What they build
Known for
health caremedical innovationorthobiologicsbiocompatible materialbiomechanical propertiesmanufacturingmedical patentsbiomimicry in medicinemedical researchmedical equipment manufacturingimplantable productsorthopaedicssilk nanofiber technologymedical device innovationsilk fibroin compositesbiocompatible scaffold
Built with from their website
Google Tag ManagerGoogle WorkspaceViewport MetaGoogle MeetMicrosoft ExchangeCookiebotGoogle FormsMicrosoft 365 Apps & ServicesNuxtjsMobile Friendly
Blue Host DNSOpen GraphRuby On RailsRubyNetlifyBlue HostGoogle AnalyticsVimeo
Add your raise, your deck and your story, and put KLISBio in front of investors. Or tell us what we have wrong.